81 results
We have defined the following milestones/deliverables for this project:1. Evaluation of IgG antibody response in pregnant women after participation in the Dutch national COVID-19 vaccination program.2. Evaluation of the relation between gestational…
The main objective of our research is to study the effectiveness of the SAFER pregnancy intervention in reducing risk behaviour (i.e. smoking and alcohol use) in pregnant women and women with the wish to conceive. The secondary objectives focus on…
To determine if paracetamol can be used effectively and accurately in determining plasma volume as compared to the gold standard of 125I labeled ablumin in a non-pregnant patient population scheduled for plasmavolume measurement by I-125.
The main objective of the Brabant Study (BS) is to investigate possible different trajectories of thyroid function during pregnancy taking hCG hormone into account. Moreover, we aim to investigate whether pregnancy complications (e.g. pre-eclampsia…
PrimaryTo examine the pharmacokinetics of standard antibiotic regimen used at the department of Obstetrics at the Erasmus MC for postsurgical prophylaxis after caesarean section.Secondary- To examine the relation between the weight category (1. BMI…
The aim of the NEtherlands Chlamydia Cohort STudy (NECCST) is to assess the risk of developing complications and the time to pregnancy in women with and without a known previous Ct infection. Furthermore, this study aims at determining host genetic…
The main objectives are to investigate whether our product is suitable for the target group, to identify barriers to wider implementation in mainstream care, and to gather patient experience and feedback. We want to know if patients perceive the…
The primary objective of this study is to expand the knowledge about pregnant women with PTSD (symptomatology). Pregnant women with PTSD (symptomatology) will be described, ass wel ass the pregnant women who develop PTSD (symptomatology) during…
To determine the workability of the non-invasive abdominal electrode patch for implementation in clinical practice.
With this study we aim to increase our understanding of perinatal mental health in migrant and refugee mothers, exploring potential risk and protective factors for PMCs from pregnancy up to 6 months after birth. We also aim to explore the…
Primary Objectives: Determine oncologic outcomes after fertility-sparing treatment in AYAs with cervical, ovarian or endometrial cancer (Q1). Determine fertility and obstetric outcomes after fertility-sparing treatment in AYAs with cervical, ovarian…
To establish a functional working protocol to analyze, characterize and determine the microbiome (including the virome) and its metabolome of the placenta, neonate and periconceptional semen and vaginal/cervical/uterine/rectal environment.
1. Develop non-invasive PGT based on cfDNA in SCM (i.e. waste material) of IVF embryos generated for PGT-M and PGT-SR.2. Develop non-invasive PGT for aneuploidy origin (niPGT-AO) to assess the rate of aneuploidies and the origin and assess the…
To assess the inter- and intra-variabiltiy of the Uterine Artery Doppler measurement in first trimester pregnancies.
Aims of this study is to explore factors that are related to (sub)optimal mother-child bonding in mothers with mental health disorders.
This study aims to identify what the most suitable and acceptable method is to create space to discuss psychiatric disorders symptoms in pregnant asylum seekers.
Primary objective:Are postpartum PTSD symptoms an independent predictor for impaired mother-child bonding, or does insecure attachment in mothers, also play a role in this?
1. Our finding that measuring MEP at 12 weeks gestation could be an important marker for normal or abnormal delivery which needs to be confirmed in a separate study. 2. To measure the echogenicity of the uterus (myometrium), cervix and vastus…
To assess the inter- and intra-variability of MCA PI, UA PI, UtA PI and CPR between 32 and 40 weeks of gestation.
1. To investigate the glucose and insulin responses after the MTT enriched with labelled glucose early (12-16 weeks), mid pregnancy (24-28 weeks) and postpartum (3 months) 2. Compare the MTT results with the standard OGTT testing at 24-28 weeks (in…